A Real‐World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B‐Cell Lymphoma

L Elizabeth Budde, Adam J Olszewski, Bei Hu, Nikesh N Shah, Connie Lee Batlevi, Shen Yin, Iris To, Michael C Wei, Martine Joanna Kallemeijn, Lisa Musick, Linda Lundberg, Natasha Shamas, Mark Dixon, Navdeep Pal, Ashwini Shewade, Jason Westin · 2026

Read A Real‐World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B‐Cell Lymphoma by L Elizabeth Budde, Adam J Olszewski, Bei Hu, Nikesh N Shah, Connie Lee Batlevi, Shen Yin, Iris To, Michael C Wei, Martine Joanna Kallemeijn, Lisa Musick, Linda Lundberg, Natasha Shamas, Mark Dixon, Navdeep Pal, Ashwini Shewade, Jason Westin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13472062.txt.

Description

L Elizabeth Budde and co-authors describe how a three-drug salvage regimen performs in everyday United States lymphoma care, in a 2026 study. Rituximab with gemcitabine and oxaliplatin is a standard fallback when large B-cell lymphoma returns, yet community data were thin. Health records for 281 patients treated from 2011 to 2023, mostly in community clinics, supplied the picture.

About forty-five percent responded and twenty-two percent cleared the cancer completely, but the typical patient progressed within three months and lived about a year. Those treated at first relapse did clearly better than patients treated later. The authors offer the numbers as a real-world benchmark for judging newer options.

Catalog record

CREATORL Elizabeth Budde, Adam J Olszewski, Bei Hu, Nikesh N Shah, Connie Lee Batlevi, Shen Yin, Iris To, Michael C Wei, Martine Joanna Kallemeijn, Lisa Musick, Linda Lundberg, Natasha Shamas, Mark Dixon, Navdeep Pal, Ashwini Shewade, Jason Westin
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13472062

Browse the full library · About the Tower of Babel